Ｍ－ＳＯＳＥＩ（4565）　Sosei Heptares Notes that its Partnered Adenosine A2a Antagonist Imaradenant (AZD4635) has been Removed from AstraZeneca’s Clinical Pipeline 2021/11/12
/-
読み込み中…